BUCHI J KEVIN 4
4 · Benitec Biopharma Inc. · Filed Jun 30, 2026
Research Summary
AI-generated summary of this filing
Benitec Biopharma Director Kevin J. Buchi Gifts 51,813 Shares
What Happened
Kevin J. Buchi, a director of Benitec Biopharma Inc. (BNTC), disposed of 51,813 shares on 2026-06-29 as a gift (transaction code G). The shares were transferred at $0.00 per share (gift), resulting in no cash proceeds reported on the Form 4.
Key Details
- Transaction date: 2026-06-29; filing date: 2026-06-30 (Form 4) — appears timely under Form 4 reporting rules.
- Transaction type/code: Gift (G). Reported price: $0.00 per share.
- Shares transferred: 51,813. Total cash proceeds: $0 (gift).
- Shares owned after the transaction: Not specified in the material provided.
- Footnote: The reporting person transferred the shares to a donor-advised fund sponsored by a Section 501(c)(3) charitable organization.
- No indication of option exercise, sale for cash, or 10% ownership change in the provided filing.
Context
Gifts to donor-advised funds are charitable transfers and are not the same as market sales; they do not necessarily signal the insider’s view on the company’s prospects. Donor-advised funds allow the donor to recommend grants to charities later, but the filing simply records the transfer of beneficial ownership.
Insider Transaction Report
Form 4
BUCHI J KEVIN
Director
Transactions
- Gift
Common Stock
[F1]2026-06-29−51,813→ 52,097 total
Footnotes (1)
- [F1]The reporting person transferred 51,813 shares of Benitec Biopharma Inc. common stock to a donor-advised fund sponsored by a charitable organization under Section 501(c)(3) of the Internal Revenue Code.
Signature
/s/ J. Kevin Buchi|2026-06-30